US deploys autonomous blood collection robot
The U.S. Food and Drug Administration (FDA) has announced approval for Aletta, the first autonomous robot capable of drawing blood from a patient's arm. The device has been approved for marketing by Vitestro. It is used in outpatient clinics for adults under the supervision of a trained specialist who can operate three devices simultaneously. The device utilizes infrared and ultrasound technologies to locate the vein and automatically performs all steps of the blood draw process, achieving a success rate equal to or better than trained medical professionals. It also exhibits rare and mild side effects. The approval aims to improve blood collection services and reduce the workload on healthcare providers, especially amid a shortage of trained personnel, while ensuring safety and efficiency in the procedures.
Notice: This Is an AI-Generated Summary
Comments (0)